FDA panel recommends Pfizer’s low-dose Covid vaccine for kids ages 5 to 11A key Food and Drug Administration advisory committee on Tuesday recommended a lower dose of Pfizer and BioNTech’s Covid-19 vaccine for children ages 5 to 11, a critical step in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads.
BIAS COVERAGE DISTRIBUTION
FDA advisers back Pfizer’s COVID-19 vaccine for young kids
A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer's COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11. A Food and Drug Administration advisory panel voted unanimously with one abstention that the vaccine's benefits in preventing COVID-19 in that age group outweigh any potential risks — including a heart-related side effect that's been very rare in teens and young adults who get…
FDA advisory committee recommends authorizing Pfizer's COVID vaccine for kids
The U.S. Food and Drug Administration isn't bound by the committee's recommendation, but is expected to consider it and make a decision in the coming days on whether to approve the vaccine for kids five to 11 years old.
U.S. FDA advisers back Pfizer/BioNTech COVID-19 vaccine for children
An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc and BioNTech SE COVID-19 vaccine for children ages 5 to 11, saying the benefits of inoculation outweigh the risks.
U.S. FDA Advisers Back Pfizer/BioNTech COVID-19 Vaccine For Children
An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc and BioNTech SE COVID19 vaccine for children ages 5 to 11, saying the benefits of inoculation outweigh the risks.
U.S. FDA advisers back Pfizer's COVID-19 vaccine for young kids
The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.
U.S. FDA panel backs Pfizer’s low-dose COVID-19 vaccine for children
A Food and Drug Administration advisory panel voted unanimously, that the vaccine’s benefits in preventing COVID-19 in the 5-11 age group outweigh any potential risks.
US Panel Recommends Pfizer Covid Vaccine For Younger Children
A medical panel of US government advisors endorsed the Pfizer Covid-19 vaccine in five-to-11-year-olds Tuesday, paving the way for younger children to get their shots within weeks.
FDA Advisers Back Pfizer's COVID-19 Vaccine for Kids 5 to 11 Years Old
WASHINGTON (CBS NEWS) — Pfizer’s request to roll out COVID-19 vaccines for Americans as young as 5 years old cleared a key regulatory hurdle Tuesday, after a panel of the Food and Drug Administration’s outside vaccine advisers voted by a majority to back Pfizer’s request. The vote is a crucial step towards vaccinations for younger children, but not the final word. If the FDA decides to formally authorize the vaccine, the Centers for Disease Cont…
FDA committee moves Pfizer-BioNTech COVID-19 vaccine closer to use for children ages 5-11
In children ages 5-11, the Pfizer-BioNTech vaccine was more than 90% protective against contracting symptomatic COVID-19, according to company data.
FDA panel recommends COVID-19 vaccine for ages 5-11
A key advisory panel on Tuesday recommended the Pfizer-BioNTech COVID-19 shots for emergency use in children ages 5 to 11, setting the stage for shots to become available to 28 million children by early November and fueling debate over the risks and rewards of vaccinating an age group that’s accounted for 0.01% of COVID-19 deaths in America.